Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
Holmgaard, Rikke B., Zamarin, Dmitriy, Lesokhin, Alexander, Merghoub, Taha, Wolchok, Jedd D.Language:
english
Journal:
EBioMedicine
DOI:
10.1016/j.ebiom.2016.02.024
Date:
February, 2016
File:
PDF, 1.76 MB
english, 2016